切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (03) : 205 -208. doi: 10.3877/cma.j.issn.2095-3224.2024.03.005

论著

达芬奇机器人辅助直肠及乙状结肠癌根治术的学习曲线分析
陈海鹏1, 张金珠1, 关旭1, 赵志勋1, 刘恒昌1, 姜争1, 刘正1, 王锡山1,()   
  1. 1. 100021 北京,国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院结直肠外科
  • 收稿日期:2024-04-03 出版日期:2024-06-25
  • 通信作者: 王锡山
  • 基金资助:
    中国医学科学院肿瘤医院住培教学课题(E2021008)

Analysis of the learning curve of Da Vinci robotic-assisted radical surgery for rectal and sigmoid colon cancer

Haipeng Chen1, Jinzhu Zhang1, Xu Guan1, Zhixun Zhao1, Hengchang Liu1, Zheng Jiang1, Zheng Liu1, Xishan Wang1,()   

  1. 1. Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2024-04-03 Published:2024-06-25
  • Corresponding author: Xishan Wang
引用本文:

陈海鹏, 张金珠, 关旭, 赵志勋, 刘恒昌, 姜争, 刘正, 王锡山. 达芬奇机器人辅助直肠及乙状结肠癌根治术的学习曲线分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(03): 205-208.

Haipeng Chen, Jinzhu Zhang, Xu Guan, Zhixun Zhao, Hengchang Liu, Zheng Jiang, Zheng Liu, Xishan Wang. Analysis of the learning curve of Da Vinci robotic-assisted radical surgery for rectal and sigmoid colon cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(03): 205-208.

目的

分析达芬奇机器人辅助直肠及乙状结肠癌根治术的学习曲线,探索最佳的学习例数。

方法

回顾性分析2021年7月至2022年12月于中国医学科学院肿瘤医院由同一术者完成的93例达芬奇机器人辅助直肠及乙状结肠癌根治术的临床资料。根据手术时间构建达芬奇机器人辅助直肠及乙状结肠癌根治术的学习曲线,根据曲线峰值确定最佳学习例数,并按照学习曲线将患者分为手术提高组(A组)及手术熟练组(B组),对比两组临床指标。

结果

93例患者顺利实施达芬奇机器人辅助乙状结肠或直肠癌根治术,最佳拟合曲线方程为:根据CUSUM值进行曲线拟合,曲线方程为y=0.006x3-1.183x2+58.840x-219.293,R2=0.857,P<0.01。达到学习曲线最佳手术例数为33例。将前33例患者列为A组,将之后的60例患者列为B组。与A组相比,B组的手术所需时间更短(144.3 min vs. 179.1 min,P=0.008),失血量更少(21.7 mL vs. 29.4 mL,P=0.010),术后住院时间更短(7.1 d vs. 8.8 d,P=0.026)。

结论

达芬奇机器人手术需要一定的学习例数。本研究表明33例为最佳学习例数。完成33例达芬奇机器人手术学习后,患者手术时间更短,失血量更少,术后住院时间更短。

Objective

To analyze the learning curve of Da Vinci robotic-assisted radical surgery for rectal and sigmoid colon cancer and explore the optimal number of learning cases.

Methods

A retrospective analysis was conducted on the clinical data of 93 cases of Da Vinci robotic-assisted radical surgery for rectal and sigmoid colon cancer performed by the same surgeon at the Cancer Hospital, Chinese Academy of Medical Sciences from July 2021 to December 2022. The learning curve of Da Vinci robotic-assisted radical surgery for rectal and sigmoid colon cancer was constructed based on the surgical time. The optimal number of learning cases was determined according to the peak of the curve, and patients were divided into the surgery improvement group (Group A) and the surgery proficiency group (Group B) according to the learning curve for comparison of clinical parameters.

Results

Ninety-three patients successfully underwent Da Vinci robotic-assisted radical surgery for sigmoid colon or rectal cancer. The best fitting curve equation was: curve fitting according to CUSUM values, the curve equation was y=0.006x3-1.183x2+58.840x-219.293, R2=0.857, P<0.01. The optimal number of surgeries to reach the learning curve was 33 cases. The first 33 patients were classified as the A group, and the subsequent 60 patients were classified as the B group. Compared with the Group A, the Group B had shorter operative time (144.3 min vs. 179.1 min, P=0.008), less blood loss (21.7 mL vs. 29.4 mL, P=0.010), and shorter postoperative hospital stay (7.1 d vs. 8.8 d, P=0.026).

Conclusion

Da Vinci robotic surgery requires a certain number of learning cases. This study suggests that 33 cases are the optimal number of learning cases. After completing 33 cases of Da Vinci robotic surgery learning, patients had shorter operative time, less blood loss, and shorter postoperative hospital stay.

图1 达芬奇机器人辅助直肠及乙状结肠癌学习曲线
表1 两组患者基线资料比较[,例(%)]
表2 两组患者围术期资料比较[,例(%)]
[1]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
[3]
Losurdo P, Mastronardi M, de Manzini N, et al. Survival and long-term surgical outcomes after colorectal surgery: are there any gender-related differences?[J]. Updates Surg, 2022, 74(4): 1337-1343.
[4]
Tokuhara K, Nakatani K, Ueyama Y, et al. Short- and long-term outcomes of laparoscopic surgery for colorectal cancer in the elderly: A prospective cohort study[J]. Int J Surg, 2016, 27: 66-71.
[5]
Feng Q, Yuan W, Li T, et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2022, 7(11): 991-1004.
[6]
Bokhari MB, Patel CB, Ramos-Valadez DI, et al. Learning curve for robotic-assisted laparoscopic colorectal surgery[J]. Surg Endosc, 2011, 25(3): 855-860.
[7]
Jiménez-Rodríguez RM, Díaz-Pavón JM, de la Portilla de Juan F, et al. Learning curve for robotic-assisted laparoscopic rectal cancer surgery[J]. Int J Colorectal Dis, 2013, 28(6): 815-821.
[8]
Kim YW, Lee HM, Kim NK, et al. The learning curve for robot-assisted total mesorectal excision for rectal cancer[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(5): 400-405.
[9]
冯存成, 高永建, 宋德锋, 等. 达芬奇机器人结直肠癌根治术学习曲线研究[J]. 中国临床研究, 2022, 35(8): 1073-1078.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[4] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[5] 江东根, 依力夏提·艾力, 依布拉音江·阿布力克木, 依力盼·依拉木, 冯瑶, 艾尼玩·木拉克, 艾克拜尔江·阿里木. 基层医院单一术者改良单通道腹腔镜下鞘状突环扎术学习曲线及体会[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 560-565.
[6] 张斌, 孙代宇, 胡昕, 韩菲, 李久明, 李功雨, 吴伟力, 冯宝富, 彭国辉. 评分系统预测不同经验手术者输尿管软镜术后结石清除率准确性的比较研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 353-360.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[15] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
阅读次数
全文


摘要